Persistence of recurrence risk after discharge. In whom to extend treatment and at what dose?
Congress Presentation
6 more presentations in this session
From PE diagnose to extended treatment - What changed with NOACs?
Speaker: Professor S. Konstantinides (Mainz, DE)
Using evidence to define between home and hospital - Where to treat pe?
Speaker: Professor L. Howard (London, GB)
Complex patients profiles. What is the result with NOACs?
Speaker: Professor D. Jimenez (Madrid, ES)
PE in a cancer patient - What are the roles of NOACs in cardio-oncology?
Speaker: Doctor J. Weitz (Hamilton, CA)
Panel Discussion - Managing pulmonary embolism according to patient profile in the NOAC era.
Speaker: Professor S. Konstantinides (Mainz, DE)
Access the full session
About the event
